Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Vaxcyte, Inc. per 2025 Jun 30 adalah -709.11 MM.
- Nilai net income untuk Vaxcyte, Inc. per 2025 Jun 30 adalah -547.50 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -709.11 | -547.50 | |
2025-03-31 | -635.87 | -509.62 | |
2024-12-31 | -569.55 | -463.93 | |
2024-09-30 | -604.05 | -507.65 | |
2024-06-30 | -577.16 | -497.19 | |
2024-03-31 | -511.32 | -436.82 | |
2023-12-31 | -468.04 | -402.27 | |
2023-09-30 | -357.94 | -299.51 | |
2023-06-30 | -303.49 | -264.77 | |
2023-03-31 | -264.23 | -244.96 | |
2022-12-31 | -232.26 | -223.49 | |
2022-09-30 | -175.53 | -174.00 | |
2022-06-30 | -143.90 | -142.70 | |
2022-03-31 | -119.75 | -117.84 | |
2021-12-31 | -103.67 | -100.08 | |
2021-09-30 | -93.28 | -92.25 | |
2021-06-30 | -87.63 | -86.65 | |
2021-03-31 | -85.13 | -83.30 | |
2020-12-31 | -89.58 | -89.22 | |
2020-09-30 | -85.97 | -83.10 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -3.98 | -3.98 |
2024-12-31 | -3.80 | |
2024-09-30 | -4.46 | -4.46 |
2024-06-30 | -4.59 | -4.59 |
2024-03-31 | -4.22 | -4.22 |
2023-12-31 | -4.14 | |
2023-09-30 | -3.28 | -3.28 |
2023-06-30 | -3.25 | -3.25 |
2023-03-31 | -3.40 | -3.40 |
2022-12-31 | -3.44 | |
2022-09-30 | -2.98 | -2.98 |
2022-06-30 | -2.56 | -2.56 |
2022-03-31 | -2.20 | -2.20 |
2021-12-31 | -1.93 | |
2021-09-30 | -1.79 | -1.79 |
2021-06-30 | -1.69 | -1.69 |
2021-03-31 | -2.02 | -2.02 |
2020-12-31 | -3.02 | |
2020-09-30 | -4.68 | -4.68 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Vaxcyte, Inc. per 2025 Jun 30 adalah -459.55 MM.
- Nilai cash from investing activities untuk Vaxcyte, Inc. per 2025 Jun 30 adalah -1,273.13 MM.
- Nilai kas dari aktivitas pendanaan untuk Vaxcyte, Inc. per 2025 Jun 30 adalah 1,523.22 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -459.55 | -1,273.13 | 1,523.22 |
2025-03-31 | -459.78 | -1,431.28 | 1,631.07 |
2024-12-31 | -452.63 | -2,005.67 | 2,448.51 |
2024-09-30 | -470.04 | -1,462.42 | 2,446.34 |
2024-06-30 | -466.88 | -523.12 | 979.85 |
2024-03-31 | -408.22 | -776.28 | 1,416.45 |
2023-12-31 | -296.79 | -773.31 | 639.81 |
2023-09-30 | -233.20 | -795.34 | 1,293.71 |
2023-06-30 | -214.20 | -782.91 | 1,289.18 |
2023-03-31 | -190.59 | -423.18 | 792.09 |
2022-12-31 | -170.60 | 74.58 | 861.55 |
2022-09-30 | -156.47 | 110.62 | 213.67 |
2022-06-30 | -146.34 | 57.44 | 177.25 |
2022-03-31 | -135.89 | 10.75 | 128.33 |
2021-12-31 | -121.39 | -212.31 | 17.80 |
2021-09-30 | -81.07 | -213.11 | 9.60 |
2021-06-30 | -65.71 | -194.62 | 2.03 |
2021-03-31 | -46.20 | -174.15 | 265.56 |
2020-12-31 | -46.63 | -1.10 | 374.87 |
2020-09-30 | -50.27 | -1.34 | 415.67 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Vaxcyte, Inc. pada 2025 Jun 30 adalah 1.31.
- p/tbv untuk Vaxcyte, Inc. pada 2025 Jun 30 adalah 1.31.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 1.31 | 1.31 | |
2025-03-31 | -19.28 | 2.71 | 2.71 |
2024-12-31 | 2.99 | 2.99 | |
2024-09-30 | -28.15 | 7.05 | 7.05 |
2024-06-30 | -18.82 | 4.14 | 4.14 |
2024-03-31 | 5.97 | 5.97 | |
2023-12-31 | -19.94 | 4.26 | 4.26 |
2023-09-30 | -18.05 | 3.33 | 3.33 |
2023-06-30 | -18.56 | 4.81 | 4.81 |
2023-03-31 | -13.43 | 3.15 | |
2022-12-31 | 10.54 | 10.54 | |
2022-09-30 | 3.88 | 3.88 | |
2022-06-30 | -10.78 | 3.53 | 3.53 |
2022-03-31 | -13.59 | 4.79 | 4.79 |
2021-12-31 | -13.61 | 4.10 | 4.10 |
2021-09-30 | -15.33 | 4.19 | 4.19 |
2021-06-30 | |||
2021-03-31 | -15.47 | 3.94 | 3.94 |
2020-12-31 | -14.37 | 3.71 | 3.71 |
2020-09-30 | -15.39 | 3.51 | 3.51 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Vaxcyte, Inc. pada 2025 Jun 30 adalah -0.13.
- EBIT (3 tahun) / EV untuk Vaxcyte, Inc. pada 2025 Jun 30 adalah -0.11.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.13 | -0.11 |
2025-03-31 | -0.05 | -0.04 |
2024-12-31 | -0.06 | -0.04 |
2024-09-30 | -0.04 | -0.02 |
2024-06-30 | -0.06 | -0.04 |
2024-03-31 | -0.06 | -0.03 |
2023-12-31 | -0.06 | -0.03 |
2023-09-30 | -0.06 | -0.04 |
2023-06-30 | -0.06 | -0.04 |
2023-03-31 | -0.10 | -0.07 |
2022-12-31 | -0.05 | -0.03 |
2022-09-30 | -0.12 | -0.09 |
2022-06-30 | -0.11 | -0.09 |
2022-03-31 | -0.08 | -0.06 |
2021-12-31 | -0.08 | -0.07 |
2021-09-30 | -0.07 | -0.05 |
2021-06-30 | ||
2021-03-31 | -0.08 | -0.05 |
2020-12-31 | -0.10 | -0.06 |
2020-09-30 | -0.07 | -0.02 |
Efektivitas Manajemen
- roa untuk Vaxcyte, Inc. pada 2025 Jun 30 adalah -0.24.
- roe untuk Vaxcyte, Inc. pada 2025 Jun 30 adalah -0.26.
- roic untuk Vaxcyte, Inc. pada 2025 Jun 30 adalah -0.16.
- croic untuk Vaxcyte, Inc. pada 2025 Jun 30 adalah -0.08.
- ocroic untuk Vaxcyte, Inc. pada 2025 Jun 30 adalah -0.14.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.24 | -0.26 | -0.16 | -0.08 | -0.14 |
2025-03-31 | -0.22 | -0.23 | -0.14 | -0.00 | -0.13 |
2024-12-31 | -0.36 | -0.41 | -0.15 | 0.15 | -0.14 |
2024-09-30 | -0.33 | -0.35 | -0.25 | -0.01 | -0.23 |
2024-06-30 | -0.43 | -0.46 | -0.22 | 0.11 | -0.20 |
2024-03-31 | -0.40 | -0.42 | -0.32 | -0.34 | -0.23 |
2023-12-31 | -0.73 | -0.83 | -0.21 | 0.19 | -0.16 |
2023-09-30 | -0.64 | -0.72 | -0.18 | 0.20 | -0.15 |
2023-06-30 | -0.60 | -0.67 | -0.18 | 0.20 | -0.15 |
2023-03-31 | -0.55 | -0.62 | -0.25 | 0.19 | -0.20 |
2022-12-31 | -0.49 | -0.57 | -0.46 | 0.44 | -0.41 |
2022-09-30 | -0.40 | -0.47 | -0.46 | 0.44 | -0.41 |
2022-06-30 | -0.33 | -0.37 | -0.37 | 0.22 | -0.38 |
2022-03-31 | -0.26 | -0.31 | -0.31 | 0.01 | -0.36 |
2021-12-31 | -0.23 | -0.27 | -0.33 | -1.05 | -0.26 |
2021-09-30 | -0.23 | -0.24 | -0.30 | -0.93 | -0.21 |
2021-06-30 | -0.21 | -0.23 | -0.27 | -0.81 | -0.21 |
2021-03-31 | -0.51 | -0.60 | -0.25 | 0.14 | -0.14 |
2020-12-31 | -1.36 | -1.64 | -0.26 | 0.95 | -0.13 |
2020-09-30 | -1.37 | -0.23 | 1.00 | -0.14 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1649094 |
Grupong Pang-industriya
SIC 2836 - Biological Products, Except Diagnostic Substances (Biotech) |